A PERI-TRIGONAL INJECTION PARADIGM OF ONABOTULINUMTOXINA REDUCES URINARY SYMPTOMS IN FEMALE PATIENTS AND IS ASSOCIATED WITH LOW CLEAN INTERMITTENT CATHETERIZATION USE

A PERI-TRIGONAL INJECTION PARADIGM OF ONABOTULINUMTOXINA REDUCES URINARY SYMPTOMS IN FEMALE PATIENTS AND IS ASSOCIATED WITH LOW CLEAN INTERMITTENT CATHETERIZATION USE Meeting Abstract

publication date

September 1, 2019

webpage

Web of Science

published in

INTERNATIONAL UROGYNECOLOGY JOURNAL Journal

start page

S22

end page

S22

volume

30